| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 03/06/2024 | 12:00 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NASDAQ:NBTX | Nanobiotix SA |
| 06/11/2023 | 22:12 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] | NASDAQ:NBTX | Nanobiotix SA |
| 02/11/2023 | 21:36 | Edgar (US Regulatory) | Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses | NASDAQ:NBTX | Nanobiotix SA |
| 26/09/2023 | 13:34 | IH Market News | Tuesday’s Wall Street Highlights: Ford Motor, Coty, JPMorgan, Merck, Tesla, AIG, and more | NASDAQ:NBTX | Nanobiotix SA |
| 10/07/2023 | 13:50 | IH Market News | Monday’s Wall Street Highlights: Icahn Enterprises, Nanobiotix, TSMC, Alibaba, and more | NASDAQ:NBTX | Nanobiotix SA |
| 27/06/2023 | 14:20 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | NASDAQ:NBTX | Nanobiotix SA |
| 05/05/2023 | 12:09 | Edgar (US Regulatory) | Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) | NASDAQ:NBTX | Nanobiotix SA |
| 02/02/2023 | 17:31 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:NBTX | Nanobiotix SA |
| 09/08/2022 | 22:15 | Business Wire | NANOBIOTIX : INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL | NASDAQ:NBTX | Nanobiotix SA |
| 09/08/2022 | 22:15 | Business Wire | NANOBIOTIX: Voting Rights and Shares Capital of the Company | NASDAQ:NBTX | Nanobiotix SA |
| 13/07/2022 | 22:15 | Business Wire | Half-year Report on the Nanobiotix Liquidity Contract With Gilbert Dupont | NASDAQ:NBTX | Nanobiotix SA |
| 13/07/2022 | 22:15 | Business Wire | BILAN SEMESTRIEL 2022 DU CONTRAT DE LIQUIDITÉ NANOBIOTIX AVEC LA SOCIÉTÉ DE BOURSE GILBERT DUPONT | NASDAQ:NBTX | Nanobiotix SA |
| 09/06/2022 | 22:15 | Business Wire | NANOBIOTIX: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital | NASDAQ:NBTX | Nanobiotix SA |
| 05/06/2022 | 15:00 | Business Wire | NANOBIOTIX: New Data Featuring NBTXR3 Plus Chemoradiation and in the Preoperative Setting Support Broad Applicability for Head and Neck Cancer and Other Solid Tumor Indications | NASDAQ:NBTX | Nanobiotix SA |
| 05/06/2022 | 15:00 | Business Wire | NANOBIOTIX : DE NOUVELLES DONNÉES ASSOCIANT NBTRX3 AVEC LA CHIMIOTHÉRAPIE EN PRÉOPÉRATOIRE INDIQUENT QUE NBTRX3 S’INTEGRERAIT DANS LE TRAITEMENT DU CANCER DE LA TÊTE ET DU COU ET D'AUTRES TUMEURS SOLIDES | NASDAQ:NBTX | Nanobiotix SA |
| 02/06/2022 | 22:15 | Business Wire | NANOBIOTIX Annual Shareholders’ General Meeting to Be Held on June 23, 2022 | NASDAQ:NBTX | Nanobiotix SA |
| 02/06/2022 | 22:15 | Business Wire | L’ASSEMBLÉE GÉNÉRALE MIXTE ANNUELLE DE NANOBIOTIX SE TIENDRA LE 23 JUIN 2022 | NASDAQ:NBTX | Nanobiotix SA |
| 19/05/2022 | 14:59 | Edgar (US Regulatory) | Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a) | NASDAQ:NBTX | Nanobiotix SA |
| 19/05/2022 | 03:12 | Business Wire | CORRECTING and REPLACING: NANOBIOTIX Provides First Quarter Operational and Financial Update | NASDAQ:NBTX | Nanobiotix SA |
| 19/05/2022 | 03:12 | Business Wire | CORRIGE ET REMPLACE : NANOBIOTIX FAIT LE POINT SUR SES ACTIVITÉS ET PUBLIE SES RÉSULTATS FINANCIERS POUR LE PREMIER TRIMESTRE | NASDAQ:NBTX | Nanobiotix SA |
| 18/05/2022 | 22:40 | Business Wire | NANOBIOTIX FAIT LE POINT SUR SES ACTIVITÉS ET PUBLIE SES RÉSULTATS FINANCIERS POUR LE PREMIER TRIMESTRE | NASDAQ:NBTX | Nanobiotix SA |
| 18/05/2022 | 22:40 | Business Wire | NANOBIOTIX Provides First Quarter Operational and Financial Update | NASDAQ:NBTX | Nanobiotix SA |
| 17/05/2022 | 22:15 | Business Wire | NANOBIOTIX to Present During the Jefferies Healthcare Conference in June 2022 | NASDAQ:NBTX | Nanobiotix SA |
| 17/05/2022 | 22:15 | Business Wire | NANOBIOTIX PARTICIPERA EN JUIN À LA CONFÉRENCE JEFFERIES HEALTHCARE | NASDAQ:NBTX | Nanobiotix SA |
| 11/05/2022 | 22:15 | Business Wire | NANOBIOTIX PARTICIPERA PROCHAINEMENT À DEUX CONFÉRENCES INVESTISSEURS | NASDAQ:NBTX | Nanobiotix SA |
| 11/05/2022 | 22:15 | Business Wire | NANOBIOTIX to Participate in Two Upcoming Investor Conferences | NASDAQ:NBTX | Nanobiotix SA |
| 10/05/2022 | 22:15 | Business Wire | Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital | NASDAQ:NBTX | Nanobiotix SA |
| 04/05/2022 | 22:15 | Business Wire | NANOBIOTIX to Announce First Quarter 2022 Financial Results on May 18, 2022 | NASDAQ:NBTX | Nanobiotix SA |
| 04/05/2022 | 22:15 | Business Wire | NANOBIOTIX ANNONCERA SES RÉSULTATS FINANCIERS DU PREMIER TRIMESTRE 2022, LE 18 MAI 2022 | NASDAQ:NBTX | Nanobiotix SA |
| 02/05/2022 | 22:15 | Business Wire | DE NOUVELLES DONNÉES SUR NBTXR3, PRODUIT CANDIDAT PRINCIPAL DE NANOBIOTIX, SERONT PRÉSENTÉES LORS DE LA RÉUNION ANNUELLE DE L'ASCO 2022 | NASDAQ:NBTX | Nanobiotix SA |